| Year |
Citation |
Score |
| 2023 |
Moos WH, Faller DV, Glavas IP, Kanara I, Kodukula K, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Sampani K, Steliou K, Vavvas DG. Epilepsy: Mitochondrial Connections to the 'Sacred' Disease. Mitochondrion. PMID 37582467 DOI: 10.1016/j.mito.2023.08.002 |
0.559 |
|
| 2022 |
Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Sampani K, Steliou K, Tamvakopoulos C, et al. Treatment and Prevention of Pathological Mitochondrial Dysfunction in Retinal Degeneration and in Photoreceptor Injury. Biochemical Pharmacology. 115168. PMID 35835206 DOI: 10.1016/j.bcp.2022.115168 |
0.578 |
|
| 2021 |
Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Steliou K, Tamvakopoulos C, Vavvas DG, et al. Pathogenic mitochondrial dysfunction and metabolic abnormalities. Biochemical Pharmacology. 193: 114809. PMID 34673016 DOI: 10.1016/j.bcp.2021.114809 |
0.57 |
|
| 2020 |
Moos WH, Faller DV, Glavas IP, Harpp DN, Kanara I, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Sampani K, Steliou K, Vavvas DG, Zamboni RJ, Kodukula K, et al. Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs. Bioresearch Open Access. 9: 94-105. PMID 32257625 DOI: 10.1089/Biores.2020.0004 |
0.634 |
|
| 2019 |
Porcu P, Haverkos B, Brem E, Vallurupalli A, Feldman T, Alpdogan O, Brammer JE, Bryan LJ, Barta SK, Obrzut S, Shen H, Rochford R, Baiocchi RA, Casper C, Gutheil J, ... ... Faller DV, et al. A phase Ib/II study of oral nanatinostat (N) and valganciclovir (VG) in subjects with Epstein-Barr virus (EBV)-associated lymphomas. Journal of Clinical Oncology. 37: 7551-7551. DOI: 10.1200/Jco.2019.37.15_Suppl.7551 |
0.305 |
|
| 2019 |
Porcu P, Haverkos BM, Alpdogan O, Capra M, Feldman TA, Brem E, Vallurupalli A, Brammer JE, Schriefer A, Pereira J, Tulpule A, Barta SK, Bryan LJ, Trauger R, Obrzut S, ... ... Faller DV, et al. Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refractory (R/R) Epstein-Barr Virus (EBV)-Positive B-Cell, T-Cell, and Hodgkin Lymphoma: Interim Safety and Efficacy Results from a Phase 1b/2a Study Blood. 134: 465-465. DOI: 10.1182/Blood-2019-132004 |
0.312 |
|
| 2019 |
Moos WH, Faller DV, Glavas IP, Harpp DN, Kanara I, Pinkert CA, Powers WR, Sampani K, Steliou K, Vavvas DG, Kodukula K, Zamboni RJ. Epigenetic treatment of dermatologic disorders Drug Development Research. 80: 702-713. DOI: 10.1002/Ddr.21562 |
0.576 |
|
| 2018 |
Moos WH, Faller DV, Glavas IP, Harpp DN, Irwin MH, Kanara I, Pinkert CA, Powers WR, Steliou K, Vavvas DG, Kodukula K. A New Approach to Treating Neurodegenerative Otologic Disorders. Bioresearch Open Access. 7: 107-115. PMID 30069423 DOI: 10.1089/Biores.2018.0017 |
0.633 |
|
| 2017 |
Moos WH, Faller DV, Glavas IP, Harpp DN, Irwin MH, Kanara I, Pinkert CA, Powers WR, Steliou K, Vavvas DG, Kodukula K. Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future. Bioresearch Open Access. 6: 169-181. PMID 29291141 DOI: 10.1089/Biores.2017.0036 |
0.613 |
|
| 2017 |
Kodukula K, Faller DV, Harpp DN, Kanara I, Pernokas J, Pernokas M, Powers WR, Soukos NS, Steliou K, Moos WH. Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something. Bioresearch Open Access. 6: 123-132. PMID 29098118 DOI: 10.1089/Biores.2017.0020 |
0.587 |
|
| 2016 |
Moos WH, Pinkert CA, Irwin MH, Faller DV, Kodukula K, Glavas IP, Steliou K. Epigenetic Treatment of Persistent Viral Infections. Drug Development Research. PMID 27761936 DOI: 10.1002/Ddr.21366 |
0.631 |
|
| 2016 |
Moos WH, Faller DV, Harpp DN, Kanara I, Pernokas J, Powers WR, Steliou K. Microbiota and Neurological Disorders: A Gut Feeling. Bioresearch Open Access. 5: 137-45. PMID 27274912 DOI: 10.1089/Biores.2016.0010 |
0.638 |
|
| 2016 |
Moos WH, Maneta E, Pinkert CA, Irwin MH, Hoffman ME, Faller DV, Steliou K. Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia. Drug Development Research. PMID 26899191 DOI: 10.1002/Ddr.21295 |
0.624 |
|
| 2016 |
Irwin MH, Moos WH, Faller DV, Steliou K, Pinkert CA. Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases. Drug Development Research. PMID 26899010 DOI: 10.1002/Ddr.21294 |
0.63 |
|
| 2016 |
Dai Y, Sangerman J, Luo HY, Fucharoen S, Chui DH, Faller DV, Perrine SP. Therapeutic fetal-globin inducers reduce transcriptional repression in hemoglobinopathy erythroid progenitors through distinct mechanisms. Blood Cells, Molecules & Diseases. 56: 62-9. PMID 26603726 DOI: 10.1016/J.Bcmd.2015.10.004 |
0.37 |
|
| 2015 |
Boosalis MS, Sangerman JI, White GL, Wolf RF, Shen L, Dai Y, White E, Makala LH, Li B, Pace BS, Nouraie M, Faller DV, Perrine SP. Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice. Plos One. 10: e0144660. PMID 26713848 DOI: 10.1371/Journal.Pone.0144660 |
0.333 |
|
| 2015 |
Cao J, Dai X, Wan L, Wang H, Zhang J, Goff PS, Sviderskaya EV, Xuan Z, Xu Z, Xu X, Hinds P, Flaherty KT, Faller DV, Goding CR, Wang Y, et al. The E3 ligase APC/CCdh1 promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth. Science Signaling. 8: ra87. PMID 26329581 DOI: 10.1126/Scisignal.Aab1995 |
0.32 |
|
| 2015 |
Steliou K, Faller DV, Pinkert CA, Irwin MH, Moos WH. Bioprotective carnitinoids: lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury: mitochondrial drugs come of age. Drug Development Research. 76: 167-75. PMID 26109467 DOI: 10.1002/Ddr.21258 |
0.605 |
|
| 2015 |
Zhu L, Chiao CY, Enzer KG, Stankiewicz AJ, Faller DV, Dai Y. SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27. Molecular Cancer Research : McR. 13: 41-9. PMID 25143434 DOI: 10.1158/1541-7786.Mcr-14-0239 |
0.301 |
|
| 2014 |
Zhu L, Qi J, Chiao CY, Zhang Q, Porco JA, Faller DV, Dai Y. Identification of a novel polyprenylated acylphloroglucinol‑derived SIRT1 inhibitor with cancer‑specific anti-proliferative and invasion-suppressing activities. International Journal of Oncology. 45: 2128-36. PMID 25189993 DOI: 10.3892/Ijo.2014.2639 |
0.366 |
|
| 2014 |
Perrine SP, Pace BS, Faller DV. Targeted fetal hemoglobin induction for treatment of beta hemoglobinopathies. Hematology/Oncology Clinics of North America. 28: 233-48. PMID 24589264 DOI: 10.1016/J.Hoc.2013.11.009 |
0.329 |
|
| 2014 |
Chen Z, Forman LW, Williams RM, Faller DV. Protein kinase C-δ inactivation inhibits the proliferation and survival of cancer stem cells in culture and in vivo. Bmc Cancer. 14: 90. PMID 24528676 DOI: 10.1186/1471-2407-14-90 |
0.353 |
|
| 2014 |
Takashima A, English B, Chen Z, Cao J, Cui R, Williams RM, Faller DV. Protein kinase Cδ is a therapeutic target in malignant melanoma with NRAS mutation. Acs Chemical Biology. 9: 1003-14. PMID 24506253 DOI: 10.1021/Cb400837T |
0.327 |
|
| 2014 |
Patel K, Kollory A, Takashima A, Sarkar S, Faller DV, Ghosh SK. MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression. Cancer Letters. 347: 54-64. PMID 24491408 DOI: 10.1016/J.Canlet.2014.01.020 |
0.31 |
|
| 2014 |
Dai Y, Faller DV, Sangerman JI, Fucharoen S, Perrine SP. Multiple Oral Therapeutics Suppress Repressors (LSD-1, HDACs, and BCL11A) of Gamma Globin Gene Expression Blood. 124: 2687-2687. DOI: 10.1182/Blood.V124.21.2687.2687 |
0.381 |
|
| 2014 |
Takashima A, Chen Z, English B, Williams RM, Faller DV. Abstract B36: Targeting oncogenic RAS with small molecule PKC-delta inhibitors Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Rasonc14-B36 |
0.354 |
|
| 2013 |
Rankin AM, Forman L, Sarkar S, Faller DV. Enhanced cytotoxicity from deoxyguanosine-enriched T-oligo in prostate cancer cells. Nucleic Acid Therapeutics. 23: 311-21. PMID 23971906 DOI: 10.1089/Nat.2013.0420 |
0.3 |
|
| 2013 |
Sarkar S, Faller DV. Telomere-homologous G-rich oligonucleotides sensitize human ovarian cancer cells to TRAIL-induced growth inhibition and apoptosis. Nucleic Acid Therapeutics. 23: 167-74. PMID 23634944 DOI: 10.1089/Nat.2012.0401 |
0.353 |
|
| 2013 |
Moore RL, Faller DV. SIRT1 represses estrogen-signaling, ligand-independent ERα-mediated transcription, and cell proliferation in estrogen-responsive breast cells. The Journal of Endocrinology. 216: 273-85. PMID 23169992 DOI: 10.1530/Joe-12-0102 |
0.321 |
|
| 2013 |
Pace BS, Sangerman JI, Boosalis MS, Wolf R, Dai Y, Chui DH, Makala L, Li B, Faller DV, Perrine SP. Next Generation Clinical-Stage HbF Inducers Exhibit Multiple Molecular Actions In Vitro and In Vivo and Offer Personalized Therapeutic Regimens Blood. 122: 560-560. DOI: 10.1182/Blood.V122.21.560.560 |
0.372 |
|
| 2013 |
Takashima A, Faller DV. Abstract 2342: Inhibition of protein kinase C delta induces apoptosis through JNK-H2AX pathway in melanoma. Cancer Research. 73: 2342-2342. DOI: 10.1158/1538-7445.Am2013-2342 |
0.341 |
|
| 2012 |
Steliou K, Boosalis MS, Perrine SP, Sangerman J, Faller DV. Butyrate histone deacetylase inhibitors. Bioresearch Open Access. 1: 192-8. PMID 23514803 DOI: 10.1089/Biores.2012.0223 |
0.391 |
|
| 2012 |
Ghosh SK, Perrine SP, Faller DV. Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies. Advances in Virology. 2012: 509296. PMID 22500168 DOI: 10.1155/2012/509296 |
0.304 |
|
| 2012 |
Byles V, Zhu L, Lovaas JD, Chmilewski LK, Wang J, Faller DV, Dai Y. SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis. Oncogene. 31: 4619-29. PMID 22249256 DOI: 10.1038/Onc.2011.612 |
0.316 |
|
| 2012 |
Ghosh SK, Perrine SP, Williams RM, Faller DV. Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents. Blood. 119: 1008-17. PMID 22160379 DOI: 10.1182/Blood-2011-06-362434 |
0.361 |
|
| 2012 |
Rankin AM, Sarkar S, Faller DV. Mechanism of T-oligo-induced cell cycle arrest in Mia-PaCa pancreatic cancer cells. Journal of Cellular Physiology. 227: 2586-94. PMID 21898405 DOI: 10.1002/Jcp.22997 |
0.327 |
|
| 2012 |
Sorescu GP, Forman LW, Faller DV. Effect of inhibition of protein kinase C delta (PKCδ) on pancreatic cancer cells. Journal of Clinical Oncology. 30: e14591-e14591. DOI: 10.1200/Jco.2012.30.15_Suppl.E14591 |
0.356 |
|
| 2011 |
Chen Z, Forman LW, Miller KA, English B, Takashima A, Bohacek RA, Williams RM, Faller DV. Protein kinase Cδ inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors. Endocrine-Related Cancer. 18: 759-71. PMID 21990324 DOI: 10.1530/Erc-10-0224 |
0.33 |
|
| 2011 |
Boosalis MS, Castaneda SA, Trudel M, Mabaera R, White GL, Lowrey CH, Emery DW, Mpollo MS, Shen L, Wargin WA, Bohacek R, Faller DV, Perrine SP. Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo. Blood Cells, Molecules & Diseases. 47: 107-16. PMID 21641240 DOI: 10.1016/J.Bcmd.2011.04.008 |
0.314 |
|
| 2011 |
Sarkar S, Faller DV. T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells. Oligonucleotides. 21: 47-53. PMID 21281128 DOI: 10.1089/Oli.2010.0259 |
0.323 |
|
| 2011 |
Perrine SP, Chui DH, Sangerman JI, Boosalis MS, Faller DV. An Approach for Tailoring Diverse Therapeutic Inducers of Fetal Globin to Genetic Modifier Profiles, Blood. 118: 3188-3188. DOI: 10.1182/Blood.V118.21.3188.3188 |
0.372 |
|
| 2011 |
Byles V, Zhu L, Chmilewski LK, Lovaas JD, Faller DV, Dai Y. Abstract 3417: Class III HDAC induces epithelial-to-mesenchymal transition in prostate cancer cells Cancer Research. 71: 3417-3417. DOI: 10.1158/1538-7445.Am2011-3417 |
0.316 |
|
| 2011 |
Takashima A, Faller DV. Abstract 3016: Roles of histone deacetylase inhibitors in the regulation of DNA methyltransferase 1 Cancer Research. 71: 3016-3016. DOI: 10.1158/1538-7445.Am2011-3016 |
0.339 |
|
| 2010 |
Perrine SP, Castaneda SA, Chui DH, Faller DV, Berenson RJ, Siritanaratku N, Fucharoen S. Fetal globin gene inducers: novel agents and new potential. Annals of the New York Academy of Sciences. 1202: 158-64. PMID 20712788 DOI: 10.1111/J.1749-6632.2010.05593.X |
0.343 |
|
| 2010 |
Sangerman JI, Boosalis MS, Shen L, Haigh S, Kane A, White GL, Perrine SP, Faller DV. Identification of New and Diverse Inducers of Fetal Hemoglobin with High Throughput Screening (HTS) Blood. 116: 4277-4277. DOI: 10.1182/Blood.V116.21.4277.4277 |
0.342 |
|
| 2010 |
Faller DV, Ghosh SK, Perrine SP, Williams RM, Berenson RJ. Histone Deacetylase Inhibitors: Potent Inducers of Tumor Latent EBV Thymidine Kinase Induction Blood. 116: 1831-1831. DOI: 10.1182/Blood.V116.21.1831.1831 |
0.387 |
|
| 2009 |
Romesser PB, Perlman DH, Faller DV, Costello CE, McComb ME, Denis GV. Development of a malignancy-associated proteomic signature for diffuse large B-cell lymphoma. The American Journal of Pathology. 175: 25-35. PMID 19498000 DOI: 10.2353/Ajpath.2009.080707 |
0.336 |
|
| 2009 |
Perrine SP, Mankidy R, Boosalis MS, Bieker JJ, Faller DV. Erythroid Kruppel-like factor (EKLF) is recruited to the gamma-globin gene promoter as a co-activator and is required for gamma-globin gene induction by short-chain fatty acid derivatives. European Journal of Haematology. 82: 466-76. PMID 19220418 DOI: 10.1111/J.1600-0609.2009.01234.X |
0.346 |
|
| 2009 |
Xia S, Chen Z, Forman LW, Faller DV. PKCdelta survival signaling in cells containing an activated p21Ras protein requires PDK1. Cellular Signalling. 21: 502-8. PMID 19146951 DOI: 10.1016/J.Cellsig.2008.12.002 |
0.316 |
|
| 2009 |
Zhang B, Chambers KJ, Leprince D, Faller DV, Wang S. Requirement for chromatin-remodeling complex in novel tumor suppressor HIC1-mediated transcriptional repression and growth control. Oncogene. 28: 651-61. PMID 19015639 DOI: 10.1038/Onc.2008.419 |
0.354 |
|
| 2009 |
Longe HO, Romesser PB, Rankin AM, Faller DV, Eller MS, Gilchrest BA, Denis GV. Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential. International Journal of Cancer. Journal International Du Cancer. 124: 473-82. PMID 19003960 DOI: 10.1002/Ijc.23946 |
0.328 |
|
| 2009 |
Perrine S, Faller DV, Shen L, Boosalis M, White G, Cao H, Fei R, Thomson A, Berenson R. HQK-1001 Has Additive HbF-Inducing Activity in Combination with Hydroxyurea and Decitabine. Blood. 114: 977-977. DOI: 10.1182/Blood.V114.22.977.977 |
0.328 |
|
| 2009 |
Faller DV, Ghosh S, Feldman T, Lerner A, Smith J, Goy A, Berenson R, Perrine S. Short-Term Exposure to Arginine Butyrate, in Combination with Ganciclovir, Is as Effective as Continuous Exposure for Virus-Targeted Therapy of EBV-Positive Lymphomas. Blood. 114: 4754-4754. DOI: 10.1182/Blood.V114.22.4754.4754 |
0.373 |
|
| 2009 |
Steliou K, Perrine SP, Faller DV. Lactic acid in cancer and mitochondrial disease Drug Development Research. 70: 499-511. DOI: 10.1002/Ddr.20342 |
0.326 |
|
| 2008 |
Rankin AM, Faller DV, Spanjaard RA. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity. Anti-Cancer Drugs. 19: 329-38. PMID 18454043 DOI: 10.1097/Cad.0B013E3282F5D4C2 |
0.308 |
|
| 2008 |
Blanton WP, Wang F, Liu H, Romesser P, Faller D, Denis G. The Dual Bromodomain Protein Brd2 Controls Primary B Cell Mitogenesis and Cell Cycle in Mice Reconstituted with Lentivirus-Transduced HSCs Blood. 112: 2465-2465. DOI: 10.1182/Blood.V112.11.2465.2465 |
0.321 |
|
| 2008 |
Perrine S, Welch WC, Keefer J, Downey RL, Boosalis MS, Case S, Faller DV, Berenson R. Phase 1 Clinical Testing of HQK-1001, a Novel Oral Fetal Globin Gene Inducer Blood. 112: 130-130. DOI: 10.1182/Blood.V112.11.130.130 |
0.315 |
|
| 2007 |
Mork CN, Faller DV, Spanjaard RA. Loss of putative tumor suppressor EI24/PIG8 confers resistance to etoposide. Febs Letters. 581: 5440-4. PMID 17981155 DOI: 10.1016/J.Febslet.2007.10.046 |
0.314 |
|
| 2007 |
Xia S, Forman LW, Faller DV. Protein kinase C delta is required for survival of cells expressing activated p21RAS. The Journal of Biological Chemistry. 282: 13199-210. PMID 17350960 DOI: 10.1074/Jbc.M610225200 |
0.311 |
|
| 2007 |
Lenburg ME, Sinha A, Faller DV, Denis GV. Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis. The Journal of Biological Chemistry. 282: 4803-11. PMID 17166848 DOI: 10.1074/Jbc.M605870200 |
0.355 |
|
| 2007 |
Ghosh SK, Forman LW, Akinsheye I, Perrine SP, Faller DV. Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents. Blood Cells, Molecules & Diseases. 38: 57-65. PMID 17161633 DOI: 10.1016/J.Bcmd.2006.10.008 |
0.366 |
|
| 2007 |
Perrine SP, Hermine O, Small T, Suarez F, O'Reilly R, Boulad F, Fingeroth J, Askin M, Levy A, Mentzer SJ, Di Nicola M, Gianni AM, Klein C, Horwitz S, Faller DV. A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood. 109: 2571-8. PMID 17119113 DOI: 10.1182/Blood-2006-01-024703 |
0.325 |
|
| 2007 |
Perrine SP, Mankidy R, Boosalis MS, Bieker JJ, Faller DV. EKLF Is Recruited to the γ-Globin Gene Promoter as a Co-Activator and Is Required for γ-Globin Gene Induction by Short-Chain Fatty Acids. Blood. 110: 1771-1771. DOI: 10.1182/Blood.V110.11.1771.1771 |
0.343 |
|
| 2006 |
Mankidy R, Faller DV, Mabaera R, Lowrey CH, Boosalis MS, White GL, Castaneda SA, Perrine SP. Short-chain fatty acids induce gamma-globin gene expression by displacement of a HDAC3-NCoR repressor complex. Blood. 108: 3179-86. PMID 16849648 DOI: 10.1182/Blood-2005-12-010934 |
0.342 |
|
| 2006 |
Bohacek R, Boosalis MS, McMartin C, Faller DV, Perrine SP. Identification of novel small-molecule inducers of fetal hemoglobin using pharmacophore and 'PSEUDO' receptor models. Chemical Biology & Drug Design. 67: 318-28. PMID 16784456 DOI: 10.1111/J.1747-0285.2006.00386.X |
0.325 |
|
| 2006 |
Abujamra AL, Spanjaard RA, Akinsheye I, Zhao X, Faller DV, Ghosh SK. Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism. Virology. 345: 390-403. PMID 16289658 DOI: 10.1016/J.Virol.2005.10.003 |
0.337 |
|
| 2006 |
Longe HO, Sinha A, Faller DV, Denis GV. Telomere-Based Pre-Clinical Therapy of Human Lymphoid Malignancy in a SCID Xenograft Model. Blood. 108: 4761-4761. DOI: 10.1182/Blood.V108.11.4761.4761 |
0.328 |
|
| 2006 |
Perrine S, Trudel M, Castaneda SA, Mankidy R, Boosalis MS, Eiymo M, White GL, Bohacek R, Faller DV. A New Generation of γGlobin Gene Inducers Act on Novel Molecular and Cellular Targets. Blood. 108: 1580-1580. DOI: 10.1182/Blood.V108.11.1580.1580 |
0.348 |
|
| 2005 |
Sinha A, Faller DV, Denis GV. Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A. The Biochemical Journal. 387: 257-69. PMID 15548137 DOI: 10.1042/Bj20041793 |
0.317 |
|
| 2005 |
Chen JS, Faller DV. Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts. Journal of Cellular Physiology. 202: 87-99. PMID 15389542 DOI: 10.1002/Jcp.20094 |
0.365 |
|
| 2005 |
Mankidy R, Faller DV, Boosalis MS, Bohacek R, Perrine SP. Mechanisms of γ-Globin Gene Promoter Activation by HBF-Inducing Short Chain Fatty Acid Derivatives. Blood. 106: 826-826. DOI: 10.1182/Blood.V106.11.826.826 |
0.351 |
|
| 2005 |
Longe H, Faller DV, Denis GV. Telomere-Based Pre-Clinical Therapy in a Murine Model of Non-Hodgkin’s Lymphoma of the Diffuse Large B Cell (DLCL)Type. Blood. 106: 607-607. DOI: 10.1182/Blood.V106.11.607.607 |
0.324 |
|
| 2004 |
Liou JS, Chen JS, Faller DV. Characterization of p21Ras-mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell lines. Journal of Cellular Physiology. 198: 277-94. PMID 14603530 DOI: 10.1002/Jcp.10409 |
0.354 |
|
| 2004 |
Greenwald RJ, Tumang JR, Sinha A, Currier N, Cardiff RD, Rothstein TL, Faller DV, Denis GV. E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia. Blood. 103: 1475-84. PMID 14563639 DOI: 10.1182/Blood-2003-06-2116 |
0.316 |
|
| 2003 |
Chen JS, Faller DV, Spanjaard RA. Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics? Current Cancer Drug Targets. 3: 219-36. PMID 12769690 DOI: 10.2174/1568009033481994 |
0.391 |
|
| 2003 |
Abujamra AL, Faller DV, Ghosh SK. Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication. Virology. 309: 294-305. PMID 12758176 DOI: 10.1016/S0042-6822(03)00069-2 |
0.309 |
|
| 2003 |
van de Mark K, Chen JS, Steliou K, Perrine SP, Faller DV. Alpha-lipoic acid induces p27Kip-dependent cell cycle arrest in non-transformed cell lines and apoptosis in tumor cell lines. Journal of Cellular Physiology. 194: 325-40. PMID 12548552 DOI: 10.1002/Jcp.10205 |
0.316 |
|
| 2002 |
Park JH, Faller DV. Epstein-Barr virus latent membrane protein-1 induction by histone deacetylase inhibitors mediates induction of intercellular adhesion molecule-1 expression and homotypic aggregation. Virology. 303: 345-63. PMID 12490396 DOI: 10.1006/Viro.2002.1638 |
0.36 |
|
| 2002 |
Pace BS, White GL, Dover GJ, Boosalis MS, Faller DV, Perrine SP. Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo. Blood. 100: 4640-8. PMID 12393583 DOI: 10.1182/Blood-2002-02-0353 |
0.345 |
|
| 2002 |
Krishna S, Brown N, Faller DV, Spanjaard RA. Differential effects of short-chain fatty acids on head and neck squamous carcinoma cells. The Laryngoscope. 112: 645-50. PMID 12150517 DOI: 10.1097/00005537-200204000-00010 |
0.317 |
|
| 2002 |
Wang S, Zhang B, Faller DV. Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growth. The Embo Journal. 21: 3019-28. PMID 12065415 DOI: 10.1093/Emboj/Cdf302 |
0.342 |
|
| 2001 |
Faller DV, Mentzer SJ, Perrine SP. Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies. Current Opinion in Oncology. 13: 360-7. PMID 11555713 DOI: 10.1097/00001622-200109000-00008 |
0.337 |
|
| 2001 |
Mentzer SJ, Perrine SP, Faller DV. Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate. Transplant Infectious Disease : An Official Journal of the Transplantation Society. 3: 177-85. PMID 11493400 DOI: 10.1034/J.1399-3062.2001.003003177.X |
0.351 |
|
| 2001 |
Demary K, Wong L, Liou JS, Faller DV, Spanjaard RA. Redox control of retinoic acid receptor activity: a novel mechanism for retinoic acid resistance in melanoma cells. Endocrinology. 142: 2600-5. PMID 11356710 DOI: 10.1210/Endo.142.6.8201 |
0.319 |
|
| 2001 |
Boosalis MS, Bandyopadhyay R, Bresnick EH, Pace BS, Van DeMark K, Zhang B, Faller DV, Perrine SP. Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation. Blood. 97: 3259-67. PMID 11342457 DOI: 10.1182/Blood.V97.10.3259 |
0.387 |
|
| 2001 |
Lynch EM, Moreland RB, Ginis I, Perrine SP, Faller DV. Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro. American Journal of Physiology. Cell Physiology. 280: C897-911. PMID 11245607 DOI: 10.1152/Ajpcell.2001.280.4.C897 |
0.343 |
|
| 2000 |
Ghosh SK, Roy-Burman P, Faller DV. Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression. Journal of Virology. 74: 9742-8. PMID 11000248 DOI: 10.1128/Jvi.74.20.9742-9748.2000 |
0.343 |
|
| 2000 |
Liou JS, Chen CY, Chen JS, Faller DV. Oncogenic ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species. The Journal of Biological Chemistry. 275: 39001-11. PMID 10967125 DOI: 10.1074/Jbc.M007154200 |
0.305 |
|
| 2000 |
Hsing A, Faller DV, Vaziri C. DNA-damaging aryl hydrocarbons induce Mdm2 expression via p53-independent post-transcriptional mechanisms. The Journal of Biological Chemistry. 275: 26024-31. PMID 10856296 DOI: 10.1074/Jbc.M002455200 |
0.334 |
|
| 2000 |
Guo N, Faller DV, Vaziri C. A novel DNA damage checkpoint involving post-transcriptional regulation of cyclin A expression. The Journal of Biological Chemistry. 275: 1715-22. PMID 10636867 DOI: 10.1074/Jbc.275.3.1715 |
0.333 |
|
| 1999 |
Chen CY, Faller DV. Selective inhibition of protein kinase C isozymes by Fas ligation. The Journal of Biological Chemistry. 274: 15320-8. PMID 10336417 DOI: 10.1074/Jbc.274.22.15320 |
0.33 |
|
| 1999 |
Ghosh SK, Faller DV. Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1. Journal of Virology. 73: 4931-40. PMID 10233955 DOI: 10.1128/Jvi.73.6.4931-4940.1999 |
0.354 |
|
| 1999 |
Bandyopadhyay RS, Faller DV. Establishment of order in the flow of genetic information in cells. Cell Biochemistry and Biophysics. 30: 35-70. PMID 10099822 DOI: 10.1007/Bf02737884 |
0.312 |
|
| 1999 |
Faller DV. Endothelial cell responses to hypoxic stress. Clinical and Experimental Pharmacology & Physiology. 26: 74-84. PMID 10027074 DOI: 10.1046/J.1440-1681.1999.02992.X |
0.327 |
|
| 1999 |
Atweh GF, Sutton M, Nassif I, Boosalis V, Dover GJ, Wallenstein S, Wright E, McMahon L, Stamatoyannopoulos G, Faller DV, Perrine SP. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood. 93: 1790-1797. DOI: 10.1182/Blood.V93.6.1790.406K27_1790_1797 |
0.318 |
|
| 1998 |
Phelan MW, Forman LW, Perrine SP, Faller DV. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. The Journal of Laboratory and Clinical Medicine. 132: 519-29. PMID 9851743 DOI: 10.1016/S0022-2143(98)90131-7 |
0.32 |
|
| 1998 |
Chen CY, Liou J, Forman LW, Faller DV. Correlation of genetic instability and apoptosis in the presence of oncogenic Ki-Ras. Cell Death and Differentiation. 5: 984-95. PMID 9846185 DOI: 10.1038/Sj.Cdd.4400448 |
0.338 |
|
| 1998 |
Ikuta T, Atweh G, Boosalis V, White GL, Da Fonseca S, Boosalis M, Faller DV, Perrine SP. Cellular and molecular effects of a pulse butyrate regimen and new inducers of globin gene expression and hematopoiesis. Annals of the New York Academy of Sciences. 850: 87-99. PMID 9668531 DOI: 10.1111/J.1749-6632.1998.Tb10466.X |
0.366 |
|
| 1998 |
Chen CY, Liou J, Forman LW, Faller DV. Differential regulation of discrete apoptotic pathways by Ras. The Journal of Biological Chemistry. 273: 16700-9. PMID 9642224 DOI: 10.1074/Jbc.273.27.16700 |
0.308 |
|
| 1998 |
Mentzer SJ, Fingeroth J, Reilly JJ, Perrine SP, Faller DV. Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma. Blood Cells, Molecules & Diseases. 24: 114-23. PMID 9628848 DOI: 10.1006/Bcmd.1998.0178 |
0.345 |
|
| 1998 |
Ikuta T, Kan YW, Swerdlow PS, Faller DV, Perrine SP. Alterations in Protein-DNA Interactions in the γ-Globin Gene Promoter in Response to Butyrate Therapy Blood. 92: 2924-2933. DOI: 10.1182/Blood.V92.8.2924.420K16_2924_2933 |
0.363 |
|
| 1997 |
Boosalis MS, Ikuta T, Pace BS, da Fonseca S, White GL, Faller DV, Perrine SP. Abrogation of IL-3 requirements and stimulation of hematopoietic cell proliferation in vitro and in vivo by carboxylic acids. Blood Cells, Molecules & Diseases. 23: 434-42. PMID 9454687 DOI: 10.1006/Bcmd.1997.0162 |
0.338 |
|
| 1997 |
Faller DV, Weng H, Graves DT, Choi SY. Moloney murine leukemia virus long terminal repeat activates monocyte chemotactic protein-1 protein expression and chemotactic activity. Journal of Cellular Physiology. 172: 240-52. PMID 9258345 DOI: 10.1002/(Sici)1097-4652(199708)172:2<240::Aid-Jcp11>3.0.Co;2-D |
0.346 |
|
| 1997 |
Bandyopadhyay RS, Faller DV. Regulation of c-jun gene expression in endothelial cells by the protein kinase inhibitor staurosporine. Endothelium : Journal of Endothelial Cell Research. 5: 95-105. PMID 9237043 DOI: 10.3109/10623329709079867 |
0.336 |
|
| 1997 |
Ginis I, Faller DV. Protection from apoptosis in human neutrophils is determined by the surface of adhesion. The American Journal of Physiology. 272: C295-309. PMID 9038836 DOI: 10.1152/Ajpcell.1997.272.1.C295 |
0.304 |
|
| 1997 |
Faller DV, Weng H, Choi SY. Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat. Virology. 227: 331-42. PMID 9018132 DOI: 10.1006/Viro.1996.8345 |
0.338 |
|
| 1997 |
Choi SY, van de Mark K, Faller DV. Identification of a cis-acting element in the class I major histocompatibility complex gene promoter responsive to activation by retroviral sequences. Journal of Virology. 71: 965-70. PMID 8995614 DOI: 10.1128/Jvi.71.2.965-970.1997 |
0.312 |
|
| 1996 |
Torkelson S, White B, Faller DV, Phipps K, Pantazis C, Perrine SP. Erythroid progenitor proliferation is stimulated by phenoxyacetic and phenylalkyl acids. Blood Cells, Molecules & Diseases. 22: 150-8. PMID 8931955 DOI: 10.1006/Bcmd.1996.0022 |
0.322 |
|
| 1996 |
Chen CY, Forman LW, Faller DV. Calcium-dependent immediate-early gene induction in lymphocytes is negatively regulated by p21Ha-ras. Molecular and Cellular Biology. 16: 6582-92. PMID 8887687 DOI: 10.1128/Mcb.16.11.6582 |
0.314 |
|
| 1996 |
Vaziri C, Schneider A, Sherr DH, Faller DV. Expression of the aryl hydrocarbon receptor is regulated by serum and mitogenic growth factors in murine 3T3 fibroblasts. The Journal of Biological Chemistry. 271: 25921-7. PMID 8824226 DOI: 10.1074/Jbc.271.42.25921 |
0.333 |
|
| 1996 |
Mentzer SJ, Longtine J, Fingeroth J, Reilly JJ, DeCamp MM, O'Donnell W, Swanson SJ, Faller DV, Sugarbaker DJ. Immunoblastic lymphoma of donor origin in the allograft after lung transplantation. Transplantation. 61: 1720-5. PMID 8685950 DOI: 10.1097/00007890-199606270-00010 |
0.301 |
|
| 1996 |
Vaziri C, Faller DV. Down-regulation of platelet-derived growth factor receptor expression during terminal differentiation of 3T3-L1 pre-adipocyte fibroblasts. The Journal of Biological Chemistry. 271: 13642-8. PMID 8662875 DOI: 10.1074/Jbc.271.23.13642 |
0.339 |
|
| 1996 |
Phelan MW, Faller DV. Hypoxia decreases constitutive nitric oxide synthase transcript and protein in cultured endothelial cells. Journal of Cellular Physiology. 167: 469-76. PMID 8655601 DOI: 10.1002/(Sici)1097-4652(199606)167:3<469::Aid-Jcp11>3.0.Co;2-# |
0.344 |
|
| 1996 |
Chen CY, Faller DV. Phosphorylation of Bcl-2 protein and association with p21Ras in Ras-induced apoptosis. The Journal of Biological Chemistry. 271: 2376-9. PMID 8576193 DOI: 10.1074/Jbc.271.5.2376 |
0.308 |
|
| 1996 |
Comenzo R, Vosburgh E, Simms R, Bergethon P, Sarnacki D, Finn K, Dubrey S, Faller D, Wright D, Falk R, Skinner M. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients Blood. 88: 2801-2806. DOI: 10.1182/Blood.V88.7.2801.Bloodjournal8872801 |
0.306 |
|
| 1995 |
Faller DV, Perrine SP. Butyrate in the treatment of sickle cell disease and beta-thalassemia. Current Opinion in Hematology. 2: 109-17. PMID 9371980 DOI: 10.1097/00062752-199502020-00002 |
0.366 |
|
| 1995 |
Weng H, Choi SY, Faller DV. The Moloney leukemia retroviral long terminal repeat trans-activates AP-1-inducible genes and AP-1 transcription factor binding. The Journal of Biological Chemistry. 270: 13637-44. PMID 7775415 DOI: 10.1074/Jbc.270.23.13637 |
0.335 |
|
| 1995 |
Mundschau LJ, Faller DV. Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction. The Journal of Biological Chemistry. 270: 3100-6. PMID 7531699 DOI: 10.1074/Jbc.270.7.3100 |
0.333 |
|
| 1995 |
Choi SY, Faller DV. A transcript from the long terminal repeats of a murine retrovirus associated with trans activation of cellular genes. Journal of Virology. 69: 7054-60. PMID 7474125 DOI: 10.1128/Jvi.69.11.7054-7060.1995 |
0.341 |
|
| 1994 |
Perrine SP, Dover GH, Daftari P, Walsh CT, Jin Y, Mays A, Faller DV. Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitro and in vivo. British Journal of Haematology. 88: 555-61. PMID 7529533 DOI: 10.1111/J.1365-2141.1994.Tb05073.X |
0.335 |
|
| 1993 |
Ginis I, Mentzer SJ, Faller DV. Hypoxia induces lymphocyte adhesion to human mesenchymal cells via an LFA-1-dependent mechanism. The American Journal of Physiology. 264: C617-24. PMID 7681624 DOI: 10.1152/Ajpcell.1993.264.3.C617 |
0.304 |
|
| 1993 |
Perrine SP, Ginder GD, Faller DV, Dover GH, Ikuta T, Witkowska HE, Cai SP, Vichinsky EP, Olivieri NF. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. The New England Journal of Medicine. 328: 81-6. PMID 7677966 DOI: 10.1056/Nejm199301143280202 |
0.318 |
|
| 1989 |
Perrine SP, Swerdlow P, Faller DV, Qin G, Rudolph AM, Reczek J, Kan YW. Butyric acid modulates developmental globin gene switching in man and sheep. Advances in Experimental Medicine and Biology. 271: 177-83. PMID 2484761 DOI: 10.1007/978-1-4613-0623-8_18 |
0.318 |
|
| 1988 |
Faller DV, Kourembanas S, Ginsberg D, Hannan R, Collins T, Ewenstein BM, Pober JS, Tantravahi R. Immortalization of human endothelial cells by murine sarcoma viruses, without morphologic transformation. Journal of Cellular Physiology. 134: 47-56. PMID 2826502 DOI: 10.1002/Jcp.1041340106 |
0.307 |
|
| Show low-probability matches. |